Whole genome sequencing in the clinic: empowerment or too much information?
- PMID: 29431109
- PMCID: PMC5798981
- DOI: 10.1503/cmaj.180076
Whole genome sequencing in the clinic: empowerment or too much information?
Conflict of interest statement
Competing interests: Robert Hegele has received honorariums for membership on advisory boards and speakers’ bureaus for Akcea and Ionis, Aegerion Pharmaceuticals, Amgen, Gemphire Therapeutics, Regeneron Pharmaceuticals, Sanofi and Valeant, outside the submitted work. No other competing interests were declared. This article was solicited and has not been peer reviewed.
Comment on
-
The Personal Genome Project Canada: findings from whole genome sequences of the inaugural 56 participants.CMAJ. 2018 Feb 5;190(5):E126-E136. doi: 10.1503/cmaj.171151. CMAJ. 2018. PMID: 29431110 Free PMC article.
References
-
- Bick D, Dimmock D. Whole exome and whole genome sequencing. Curr Opin Pediatr 2011;23:594–600. - PubMed
-
- Farhan SM, Hegele RA. Genetics 101 for cardiologists: rare genetic variants and monogenic cardiovascular disease. Can J Cardiol 2013;29:18–22. - PubMed
-
- Boycott KM, Vanstone MR, Bulman DE, et al. Rare-disease genetics in the era of next-generation sequencing: discovery to translation. Nat Rev Genet 2013;14:681–91. - PubMed
Publication types
MeSH terms
LinkOut - more resources
Full Text Sources
Other Literature Sources